Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk

R. Pleava (Timisoara (Timis), Romania), S. Frent (Timisoara (Timis), Romania), C. Ardelean (Timisoara (Timis), Romania), S. Mosteoru (Timisoara (Timis), Romania), D. Gaita (Timisoara (Timis), Romania), S. Mihaicuta (Timisoara (Timis), Romania)

Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Pleava (Timisoara (Timis), Romania), S. Frent (Timisoara (Timis), Romania), C. Ardelean (Timisoara (Timis), Romania), S. Mosteoru (Timisoara (Timis), Romania), D. Gaita (Timisoara (Timis), Romania), S. Mihaicuta (Timisoara (Timis), Romania). Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk. 2529

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Pulse-rate variability during sleep studies predicts stroke risk in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021



Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001


Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008


Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities
Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018
Year: 2018



The effects of obstructive sleep apnea syndrome on cognitive and cardiovascular functioning in children with obesity
Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood
Year: 2012

Renal impairment: potentially under-stated in patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 592s
Year: 2007

Evaluation of renal function in a cohort of patients affected by obstructive sleep apnea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Increased obstructive sleep apnoea (OSA) severity is associated with increased cardiovascular risk, calculated using the RISKSCORE algorithm, and reduced left ventricular function in minimally symptomatic patients
Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea
Year: 2010


Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008

Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Obstructive sleep apnea and levels of physical activity and its association with elevated cardiovascular risk in chilean adults
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018

Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005

Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 817s
Year: 2006

Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010